Bright Green Announces Q4 2022 Financial Update; As of December 31, 2022, Bright Green Had Cash Of $414,574
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory
